These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2505990)

  • 1. Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide.
    Trischitta V; Italia S; Borzi V; Tribulato A; Mazzarino S; Squatrito S; Vigneri R
    Diabetes Care; 1989 Sep; 12(8):582-5. PubMed ID: 2505990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of combined therapies in treatment of secondary failure to glyburide.
    Trischitta V; Italia S; Mazzarino S; Buscema M; Rabuazzo AM; Sangiorgio L; Squatrito S; Vigneri R
    Diabetes Care; 1992 Apr; 15(4):539-42. PubMed ID: 1499473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?
    Trischitta V; Italia S; Raimondo M; Guardabasso V; Licciardello C; Runello F; Mazzarino S; Sangiorgi L; Anello M; Vigneri R
    J Endocrinol Invest; 1998 Dec; 21(11):744-7. PubMed ID: 9972673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure.
    Landstedt-Hallin L; Adamson U; Arner P; Bolinder J; Lins PE
    Diabetes Care; 1995 Aug; 18(8):1183-6. PubMed ID: 7587856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of NIDDM patients with secondary failure to glyburide: comparison of the addition of either metformin or bed-time NPH insulin to glyburide.
    Vigneri R; Trischitta V; Italia S; Mazzarino S; Rabuazzo MA; Squatrito S
    Diabete Metab; 1991 May; 17(1 Pt 2):232-4. PubMed ID: 1936482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure.
    Soneru IL; Agrawal L; Murphy JC; Lawrence AM; Abraira C
    Diabetes Care; 1993 Jun; 16(6):896-901. PubMed ID: 8325203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea.
    Gutniak M; Karlander SG; Efendić S
    Diabetes Care; 1987; 10(5):545-54. PubMed ID: 2890501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-insulin-dependent diabetics with secondary failure: insulin therapy at bedtime combined with glibenclamide].
    Maiz A; Arteaga A; Klaassen J; Velasco N; Borkosky M; Jiménez M; Acosta AM
    Rev Med Chil; 1993 Oct; 121(10):1135-41. PubMed ID: 8191117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short and Long Term Effects of a DPP-4 Inhibitor Versus Bedtime NPH Insulin as ADD-ON Therapy in Patients with Type 2 Diabetes.
    da Silva GM; Nogueira KC; Fukui RT; Correia MR; Dos Santos RF; da Silva ME
    Curr Pharm Des; 2016; 22(44):6716-6721. PubMed ID: 27928958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of the efficiency of ultralente insulin and NPH insulin combined with sulfonylurea in type 2 diabetes patients with secondary tolerance to sulfonylurea. Possible selection criteria].
    Sangiorgio L; Rabuazzo MA; Cordaro G; Grasso G; Condorelli L; Lunetta M
    Minerva Endocrinol; 1996 Jun; 21(2):47-52. PubMed ID: 9026680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.
    Riddle MC; Hart JS; Bouma DJ; Phillipson BE; Youker G
    Diabetes Care; 1989 Oct; 12(9):623-9. PubMed ID: 2507265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bedtime NPH insulin or metformin combined with glibenclamide in secondary sulphonylurea failure in obese type II (NIDDM) patients.
    Niazi R; Muzaffar Z
    J Pak Med Assoc; 1998 Nov; 48(11):336-8. PubMed ID: 10323055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morning or bedtime NPH insulin combined with sulfonylurea in treatment of NIDDM.
    Groop LC; Widén E; Ekstrand A; Saloranta C; Franssila-Kallunki A; Schalin-Jäntti C; Eriksson JG
    Diabetes Care; 1992 Jul; 15(7):831-4. PubMed ID: 1516500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects.
    Kawamori R; Bando K; Yamasaki Y; Kubota M; Watarai T; Iwama N; Shichiri M; Kamada T
    Diabetes Care; 1989; 12(10):680-5. PubMed ID: 2515048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination-therapy with bedtime nph insulin and sulphonylureas gives similar glycaemic control but lower weight gain than insulin twice daily in patients with type 2 diabetes.
    Olsson PO; Lindström T
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):272-7. PubMed ID: 12442064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents.
    Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
    Diabetes Technol Ther; 2004 Feb; 6(1):1-8. PubMed ID: 15000763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination daytime chlorpropamide-metformin/bedtime insulin in the treatment of secondary failures in non insulin dependent diabetes.
    Aguilar CA; Wong B; Gómez-Pérez FJ; Rull JA
    Rev Invest Clin; 1992; 44(1):71-6. PubMed ID: 1523352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bedtime intermediate-acting insulin in the treatment of secondary failure to oral hypoglycemic agents.
    Chuang LM; Lu C; Su RJ; Wu HP; Tai TY; Lin BJ
    J Formos Med Assoc; 1992 Feb; 91(2):185-9. PubMed ID: 1364216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents.
    Krempf M; Godeau T; Ranganathan S; Blanchard P; Ritz P; Charbonnel B
    Eur J Clin Pharmacol; 1992; 42(3):281-6. PubMed ID: 1577046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone.
    Lardinois CK; Liu GC; Reaven GM
    Arch Intern Med; 1985 Jun; 145(6):1028-32. PubMed ID: 3923961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.